The gold complex auranofin sensitizes platinum resistant epithelial ovarian cancer cells to cisplatin
Although numerous drugs have been tested to treat ovarian cancer (OC), survival rates remain low as there has been no major improvement from platinum (Pt)–based therapy and there is a high rate of Pt resistance in these tumors. Following several rounds of chemotherapy, OC cells develop Pt-resistance...
Saved in:
| Main Authors: | Farah H. Abdalbari, Benjamin N. Forgie, Edith Zorychta, Alicia A. Goyeneche, Abu Shadat M. Noman, Carlos M. Telleria |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-06-01
|
| Series: | Biochemistry and Biophysics Reports |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2405580825000834 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Beyond gold: the chemoenhancing mechanism and therapeutic potential of auranofin in melanoma
by: Xiaofeng Wang, et al.
Published: (2025-06-01) -
Comparison of the mechanism of antimicrobial action of the gold(I) compound auranofin in Gram-positive and Gram-negative bacteria
by: Laísa Quadros Barsé, et al.
Published: (2024-11-01) -
Repurposing auranofin combined with colistin to effectively combat fish-pathogenic Edwardsiella piscicida
by: Jinfang Lu, et al.
Published: (2025-07-01) -
Auranofin amplifies schisandrin A-induced apoptosis through ROS generation and inhibiting the PI3K/Akt pathway in hepatocellular carcinoma
by: Hyun Hwangbo, et al.
Published: (2025-06-01) -
Auranofin inhibition of thioredoxin reductase sensitizes lung neuroendocrine tumor cells (NETs) and small cell lung cancer (SCLC) cells to sorafenib as well as inhibiting SCLC xenograft growth
by: Spenser S. Johnson, et al.
Published: (2024-12-01)